| Shareholder | |||
|---|---|---|---|
| Ni XinExecutive Director | 169.30% | 880.30M | |
| Ni XinExecutive Director | 38.07% | 766.80M | |
| Shen Nan Peng | 35.88% | 186.58M | |
| OrbiMed Advisors LLC | 10.77% | 216.52M | |
| Shen Nan Peng | 8.11% | 163.10M | |
| 云南沃森生物技术股份有限公司 | 7.65% | 37.56M | |
| Li Eric | 6.76% | 135.92M | |
| DEG – Deutsche Investitions- und Entwicklungsgesellschaft mbH | 6.55% | 153.45M | |
| FORBRIGHT GLOBAL LIMITED | 6.55% | 153.45M | |
| Hillhouse Investment Management, Ltd. | 6.36% | 127.99M | |
| Hillhouse Fund IV, L.P. | 6.28% | 126.24M | |
| Temasek Capital (Private) Limited | 5.94% | 29.16M |
Holders of 5% or more of the voting shares (long positions), from the HKEXnews Disclosure of Interests consolidated list of substantial shareholders; the report date is each holder's latest filing.
This page shows the major shareholders of EDDING GENOR (06998) holding 5% or more, with stake, shares held and last filing date, and substantial shareholder disclosure-of-interest changes over the past year. Data comes from the HKEXnews Disclosure of Interests (DI) section.

